(GDRX) GoodRx Holdings, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(GDRX) GoodRx Holdings, Inc. Complete Analysis Pack
This GoodRx Holdings, Inc. 4P's Marketing Mix Analysis explains the company’s Product, Price, Place, and Promotion strategy and what it’s used for—marketing research, strategy, benchmarking, and presentations. The page shows a genuine preview/sample of the analysis so you can review format and content; purchase the full version to get the complete ready-to-use report.
Product
GoodRx’s core product is a digital prescription price-comparison tool that shows cash prices before purchase, helping shoppers find lower costs at the pharmacy counter. It reaches more than 70,000 U.S. pharmacies and gives users instant price transparency on generic and brand drugs. The product value is simple: lower out-of-pocket spend and less surprise at checkout.
GoodRx discount codes are accepted at more than 70,000 U.S. pharmacies, giving patients access to negotiated cash prices on prescription fills. This makes the product a core part of GoodRx Holdings, Inc.’s Place strategy, since it works where buying decisions happen. The codes support both one-time fills and repeat prescriptions, which helps drive recurring use.
GoodRx Gold is GoodRx Holdings, Inc.'s paid membership layer, adding recurring subscription revenue on top of the free consumer app. It offers lower cash prices on selected drugs, with plans historically priced at $9.99 a month for individuals and $19.99 a month for families. That makes the product both a savings tool for users and a higher-margin way to deepen loyalty.
Telehealth services
GoodRx Holdings, Inc. adds telehealth to its product mix, so users can move from price search to care access in one flow. This matters because the service can connect diagnosis, treatment, and a prescription without a separate office visit.
- Expands beyond drug price shopping
- Supports faster digital care access
- Bundles diagnosis, treatment, prescription
Pharma manufacturer programs
GoodRx Holdings, Inc. uses pharma manufacturer programs to give drug makers access programs that support patient affordability and medication access. This adds a B2B layer to its mix, so GoodRx is not only a consumer savings tool. It also helps manufacturers reach more patients through lower out-of-pocket costs.
- Supports affordability programs
- Expands beyond DTC savings
- Adds manufacturer-facing revenue
GoodRx Holdings, Inc.’s product is a pharmacy-price platform that lets users compare cash prices and use discount codes at more than 70,000 U.S. pharmacies. GoodRx Gold adds a paid savings tier, while telehealth extends the product from price search into care access. Pharma programs add a B2B layer and support affordability.
| Product | Role | Key data |
|---|---|---|
| Free app | Price compare | 70,000+ pharmacies |
| GoodRx Gold | Subscription | $9.99/$19.99 monthly |
| Telehealth | Care access | One flow |
What is included in the product
Detailed Word Document
Delivers a concise, company-specific 4P analysis of GoodRx’s product, price, place, and promotion strategy.
Editable Excel File
Turns GoodRx’s 4Ps into a quick, clear snapshot that eases strategy review and speeds team alignment.
Reference Sources
Lists primary, reputable sources (industry reports, government data, company filings) to speed due diligence and let investors verify GoodRx assumptions quickly.
Place
GoodRx’s U.S. digital platform runs through its website and mobile app, so price checks happen where consumers already search for drugs. It reaches millions of users and is accepted at 70,000+ pharmacies nationwide, which cuts friction and widens access without a physical store network.
GoodRx’s nationwide pharmacy access covers all 50 states, and consumers can show GoodRx prices at roughly 70,000 participating pharmacy locations. That broad reach gives GoodRx wide distribution without owning stores. It also helps the platform stay useful for both chain and independent pharmacies across the U.S.
GoodRx relies on a partner pharmacy network, not owned stores, so discounts are redeemed at the pharmacy counter where prescriptions are filled. The company says its platform connects users with more than 70,000 U.S. pharmacies, keeping the service inside the checkout flow. That gives GoodRx scale without retail capex and makes the channel a core part of prescription price shopping.
PBM-connected distribution
GoodRx Holdings, Inc. uses PBM-connected distribution to link consumers, pharmacies, and negotiated drug prices. These ties help route claims and settle transactions, so savings can flow through the network faster and with less friction. In its latest filings, GoodRx says this model supports access across a large U.S. prescription channel.
- Links price, claims, and payment flow
- Supports negotiated prescription savings
- Connects consumers and pharmacies
Santa Monica headquarters
GoodRx Holdings, Inc. is headquartered in Santa Monica, California, and that base anchors corporate operations. The setup fits a national digital model, not a store network, so the company can run platform, sales, and support work from one hub.
Santa Monica also helps GoodRx stay close to major tech, media, and talent pools in Los Angeles County, where the population tops 10 million. That matters for a business that serves users online across all 50 states.
- Headquarters: Santa Monica, California
- Corporate control is centralized there
- Built for a digital, nationwide model
GoodRx’s Place strategy is digital-first: users shop and redeem prices on its website and app, then fill prescriptions at partner pharmacies. That gives GoodRx U.S. reach without owning stores, and its network spans all 50 states and 70,000+ pharmacy locations.
| Place factor | Data |
|---|---|
| Channel | Website + mobile app |
| Pharmacy reach | 70,000+ locations |
| Coverage | All 50 states |
| HQ | Santa Monica, California |
Preview the Actual Deliverable
GoodRx Holdings, Inc. Reference Sources
The preview shown here is the actual GoodRx Holdings, Inc. 4P's Marketing Mix document you’ll receive instantly after purchase—no surprises; it’s the exact, fully complete analysis ready for immediate use.
Promotion
GoodRx’s promotion is search-led because shoppers already look online for drug prices and coupons before they buy. In 2024, the platform served 30 million+ consumers and generated $792.8 million in revenue, showing how high-intent healthcare search drives traffic and sales. So digital visibility on Google and similar channels is core to GoodRx’s marketing mix.
GoodRx can promote savings in its app and email, reaching a network tied to 70,000+ pharmacies. These channels support repeat use and retention because they make price checks and coupon use quick. Personalized refill and pricing reminders also help users act faster.
GoodRx uses digital ads to catch prescription shoppers at the moment they compare prices, when the need is immediate and practical. Its 2024 revenue was about $799 million, so paid online traffic still matters to the model. The channel pushes users to the platform fast, right at the medication-buying decision.
Television and mass media
GoodRx Holdings, Inc. uses television and mass media to make drug savings easy to grasp at scale, which fits a market where U.S. retail prescription drug spending tops $600 billion a year. Broad campaigns help turn a complex price problem into a simple consumer message: compare prices, pay less, save now. That matters because prescription costs are a mainstream pain point for millions of households.
- Mass media builds fast brand reach.
- TV explains savings in plain language.
- High drug costs make the message relevant.
Healthcare partnerships
GoodRx strengthens promotion through pharmacy and healthcare partnerships, with coupons accepted at 70,000+ U.S. pharmacies. These ties help build trust because patients see the brand inside the care pathway, not just in ads. That reach also broadens GoodRx beyond consumer marketing and supports repeat usage.
- 70,000+ pharmacy touchpoints
- Trust built through stakeholders
- Extends beyond direct ads
GoodRx promotion is search-led and tied to purchase intent, with 30 million+ consumers in 2024 and about $792.8 million in revenue. It uses SEO, paid search, app, and email to meet shoppers when they compare drug prices.
TV and mass media widen reach and make savings simple to grasp, while pharmacy and healthcare ties add trust.
| Metric | Value |
|---|---|
| Consumers served | 30 million+ |
| 2024 revenue | $792.8 million |
| Pharmacy network | 70,000+ |
Price
GoodRx’s basic platform is free, so consumers can compare drug prices and get discounts without paying upfront. In 2025, that zero-price entry point still supported broad use across millions of users, helping drive scale while GoodRx posted about $800 million in annual revenue.
The free model lowers friction for first-time users, which matters in a market where out-of-pocket prescription costs can be high. It also makes the service easy to try, then keeps users coming back when they need a lower cash price.
GoodRx Holdings, Inc. makes price its core value: discounted cash prices can cut prescription costs by up to 80% versus retail list prices, depending on the drug. Savings vary by medication, pharmacy, and location, so the same coupon can price differently across zip codes. That makes low cash cost the main reason consumers use GoodRx.
GoodRx Gold uses a paid membership model, with a $9.99/month individual plan and a $19.99/month family plan, to give heavier users deeper drug discounts. That premium tier helps GoodRx Holdings, Inc. monetize frequent shoppers beyond ad and transaction fees. In its latest reported year, GoodRx Holdings, Inc. generated about $800 million in revenue, and subscriptions remain a key way to lift recurring revenue and retention.
Variable telehealth fees
GoodRx prices telehealth separately from its free prescription comparison tools, so the consumer sees a direct service fee on top of the zero-cost search product. The fee changes by care type and provider, which lets GoodRx monetize visits without charging for the core price-comparison app.
- Free tools drive traffic; telehealth earns service fees.
- Pricing varies by visit type and care need.
- That creates a second revenue stream.
B2B negotiated economics
GoodRx also earns money from commercial deals with manufacturers and other partners, so this price line is based on contracts, not consumer price tags. That helps diversify revenue beyond patient savings, which still anchored most of GoodRx Holdings, Inc.'s model in its 2025 filings.
- Contract-based, not consumer-facing
- Used with manufacturers and partners
- Broadens revenue beyond savings
GoodRx Holdings, Inc. keeps price at the center of its model: the free app lets users compare cash prices, and savings can reach up to 80% off retail list prices, depending on drug, pharmacy, and location. That low entry price supports scale, while GoodRx reported about $800 million in 2025 revenue.
| Price lever | Key data |
|---|---|
| Free app | $0 upfront |
| GoodRx Gold | $9.99 / $19.99 per month |
| Savings | Up to 80% |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
